Ligand Pharma's market cap is currently $3.31B. The company's EPS TTM is $1.6; its P/E ratio is 48.01; Ligand Pharma is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $1.92. See an overview of income statement, balance sheet, and cash flow financials.
